These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF). De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851 [TBL] [Abstract][Full Text] [Related]
5. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor. Svedersky LP; Benton CV; Berger WH; Rinderknecht E; Harkins RN; Palladino MA J Exp Med; 1984 Mar; 159(3):812-27. PubMed ID: 6421982 [TBL] [Abstract][Full Text] [Related]
6. Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon. Kleinerman ES; Wiltrout RH; Zicht R; Fidler IJ Cancer Immunol Immunother; 1985; 20(2):151-7. PubMed ID: 3930068 [TBL] [Abstract][Full Text] [Related]
7. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity. Higuchi M; Sugimoto M; Kobayashi Y; Osawa T Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371 [TBL] [Abstract][Full Text] [Related]
8. Evidence for the identity of murine gamma interferon and macrophage activating factor. Roberts WK; Vasil A J Interferon Res; 1982; 2(4):519-32. PubMed ID: 6815284 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon. Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233 [TBL] [Abstract][Full Text] [Related]
10. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity. Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379 [TBL] [Abstract][Full Text] [Related]
12. Macrophage activation factor from EL-4, a murine T-cell line: antigenic characterization by hamster monoclonal antibodies to murine interferon-gamma. Meltzer MS; Gilbreath MJ; Crawford RM; Schreiber RD; Nacy CA Cell Immunol; 1987 Jul; 107(2):340-7. PubMed ID: 3109744 [TBL] [Abstract][Full Text] [Related]
13. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines. Nacy CA; Fortier AH; Meltzer MS; Buchmeier NA; Schreiber RD J Immunol; 1985 Nov; 135(5):3505-11. PubMed ID: 3930606 [TBL] [Abstract][Full Text] [Related]
14. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations. Schultz RM; Chirigos MA Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202 [TBL] [Abstract][Full Text] [Related]
15. Priming and triggering of tumoricidal and schistosomulicidal macrophages by two sequential lymphokine signals: interferon-gamma and macrophage cytotoxicity inducing factor 2. Krammer PH; Kubelka CF; Falk W; Ruppel A J Immunol; 1985 Nov; 135(5):3258-63. PubMed ID: 3930600 [TBL] [Abstract][Full Text] [Related]
16. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2). Hamann U; Krammer PH Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma. Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193 [TBL] [Abstract][Full Text] [Related]